Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Unknown 2

Sponsor Class

OTHER 2OTHER_GOV 1NIH 1

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Endocrine 2Other hematologic neoplasm 1Lymphoid 1

Conditions

Neuroendocrine Tumors 378Pituitary Neoplasms 158Multiple Endocrine Neoplasia Type 1 150Thyroid Cancer, Papillary 122Pheochromocytoma 107Carcinoma, Neuroendocrine 93Thyroid Neoplasms 74Paraganglioma 68Carcinoid Tumor 66Neoplasms 54Thyroid Carcinoma, Anaplastic 50Adrenocortical Carcinoma 47Adrenal Gland Neoplasms 46Neoplasm Metastasis 40Insulinoma 39Pancreatic Neoplasms 36Gastro-enteropancreatic neuroendocrine tumor 36Adenoma, Islet Cell 36Carcinoma, Medullary 29Neuroblastoma 28Adenocarcinoma, Follicular 28Hyperaldosteronism 25Prostatic Neoplasms 24Lung Neoplasms 24Obesity 23Brain Neoplasms 22Pituitary Diseases 21Differentiated Thyroid Cancer 20Cushing Syndrome 20Sarcoma 19

Interventions

Saline Solution 1Hydrocortisone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Adrenal Insufficiency × Endocrine × Clear all
NCT04890444 2022-02-14

CASE

Shanghai Jiao Tong University School of Medicine

Unknown
2,000 enrolled
Endocrine

Adrenal incidentaloma, ACTH Syndrome, Ectopic, Adrenal Cortex Neoplasms, Adrenal Insufficiency, Adrenal Hyperplasia, Congenital, Cushing Syndrome, Hyperaldosteronism, Pheochromocytoma

NCT04621565 2020-11-09

Hydrocortisone Use During Peri-operation for Pituitary Adenomas

Peking Union Medical College Hospital

Phase NA Unknown
436 enrolled
Endocrine

Adrenal Insufficiency, Pituitary Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡